Recruiting Peripheral T-Cell Lymphoma Studies in New Haven
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
The purpose of this study is to find out whether the combination treatment of romidepsin and oral azacytidine is safe and effective in patients with Peripheral T-Cell Lymphoma (PTCL). This study will ...
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
This is a single arm, open label, multicenter study phase 2 study of pembrolizumab and brentuximab in subjects with relapsed/refractory CD30 positive T-cell lymphoma (including peripheral T-cell lymph...
About Peripheral T-Cell Lymphoma Clinical Trials in New Haven
Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.
There are currently 2 peripheral t-cell lymphoma clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 82 participants. Research is being sponsored by University of Virginia, Yale University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Peripheral T-Cell Lymphoma Clinical Trials in New Haven — FAQ
Are there peripheral t-cell lymphoma clinical trials in New Haven?
Yes, there are 2 peripheral t-cell lymphoma clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What peripheral t-cell lymphoma treatments are being tested?
The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov